Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 2Expanded_access 1

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 1

Conditions

Solid Tumors 1

Interventions

tazemetostat 1pazopanib 1osunprotafib 1omburtamab I-131 1molibresib 1marizomib 1carotuximab 1Pemetrexed 1Cisplatin 1Capecitabine 1Bevacizumab 1Axitinib 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Afatinib × Other solid neoplasm × Clear all
NCT05107193 2022-11-08

Afatinib (GILOTRIF®) in Patients Suffering From Tumors Harboring Neuregulin 1 (NRG1) Gene Alterations (Specifically NRG1 Gene Fusion-positive Advanced Solid Tumors)

Boehringer Ingelheim

No longer available
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡